Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.

Tian M, Chen XS, Li LY, Wu HZ, Zeng D, Wang XL, Zhang Y, Xiao SS, Cheng Y

Open source

DOI
10.1038/s41401-026-01798-6
Published
2026 Sep
Container
Acta pharmacologica Sinica
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41401-026-01798-6,
  title = {Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.},
  author = {Tian M and Chen XS and Li LY and Wu HZ and Zeng D and Wang XL and Zhang Y and Xiao SS and Cheng Y},
  year = {2026},
  journal = {Acta pharmacologica Sinica},
  doi = {10.1038/s41401-026-01798-6},
  url = {https://doi.org/10.1038/s41401-026-01798-6}
}

RIS

TY  - JOUR
TI  - Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
AU  - Tian M
AU  - Chen XS
AU  - Li LY
AU  - Wu HZ
AU  - Zeng D
AU  - Wang XL
AU  - Zhang Y
AU  - Xiao SS
AU  - Cheng Y
PY  - 2026
JO  - Acta pharmacologica Sinica
DO  - 10.1038/s41401-026-01798-6
UR  - https://doi.org/10.1038/s41401-026-01798-6
ER  - 

APA

M, T., XS, C., LY, L., HZ, W., D, Z., XL, W., Y, Z., SS, X., & Y, C. (2026). Correction: Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01798-6

Source records